CompletedNCT00607919
Official study titleA Double-Blind Placebo Controlled Study of Atomoxetine Hydrochloride for the Treatment of ADHD in Children and Adolescents With ADHD and Comorbid Dyslexia
This study has finished and is no longer accepting participants.
Multiple locations, including IrvineADHDMedication studyAges 10–16
- Countries
- United States
- Sponsor
- Eli Lilly and Company
CompletedNCT00494819
Official study titleDiscriminate Validity of ADHD Subtypes Using Neuropsychological Test
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 7–10
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT01649232
Official study titleImplications of Electrophysiological ADHD Endophenotypes to Predict Response to Transcranial Direct-Current Stimulation
This study has finished and is no longer accepting participants.
In LiverpoolADHDObservational studyAges 8–68
- Countries
- United Kingdom
- Sponsor
- Spanish Foundation for Neurometrics Development
CompletedNCT03852966
Official study titleBetter Sleep in Psychiatric Care - ADHD. A Pragmatic Within-group Pilot Study to Develop and Evaluate Effects and Feasibility of a CBT-based Manual for Treating Sleep Problems in Adult Patients With ADHD
This study has finished and is no longer accepting participants.
In StockholmADHDBehavioural studyAges 18+
- Countries
- Sweden
- Sponsor
- Karolinska Institutet
CompletedNCT03949413
This study has finished and is no longer accepting participants.
Multiple locations, including CairoADHDObservational studyAges 60–84 months
- Countries
- Egypt
- Sponsor
- Delta University for Science and Technology
CompletedNCT01883817
What is this study about?Researchers compared DHA Omega-3 and placebo to find out how the approaches affected ADHD symptoms in people with ADHD.
This study has finished and is no longer accepting participants.
In CincinnatiADHDMedication studyAges 5–15
- Countries
- United States
- Sponsor
- University of Cincinnati
CompletedNCT00301236
What is this study about?This study evaluated the safety and effectiveness of Dexmethylphenidate HCl extended-release capsules for people with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including MesaADHDMedication studyAges 6–12
- Countries
- United States
- Sponsor
- Novartis
CompletedNCT01856686
This study has finished and is no longer accepting participants.
In LiverpoolADHDMedication studyAges 7–13
- Countries
- United Kingdom
- Sponsor
- Spanish Foundation for Neurometrics Development
CompletedNCT02614599
Official study titleNeurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 7–13
- Countries
- Sponsor
- Spanish Foundation for Neurometrics Development
CompletedNCT01841151
Official study titleDoes Neurofeedback and Working Memory Training Improve Core Symptoms of ADHD in Children and Adolescents? A Comparative, Randomized and Controlled Study.
This study has finished and is no longer accepting participants.
In StockholmADHDBehavioural studyAges 9–17
- Countries
- Sweden
- Sponsor
- Karolinska Institutet
TerminatedNCT02156089
Official study titleNeuroimaging Omega-3 and Reward in Adults With ADHD (NORAA) Trial
This study ended early.
In BethesdaADHDInterventional studyAges 18–55
- Countries
- United States
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CompletedNCT05096975
Official study titleComparative Study of the Personality Profile of Children and Adolescents With Attention Deficit Hyperactive Disorder (ADHD) With or Without Emotional Dysregulation
This study has finished and is no longer accepting participants.
In MontpellierADHDObservational studyAges 7–12
- Countries
- France
- Sponsor
- University Hospital, Montpellier